Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein HMGN1

Cancer Research

Volumn 65, Issue 15, 2005, Pages 6711-6718

  Birger, Yehudit ^a   Catez, Frédéric ^a   Furusawa, Takashi ^a   Lim, Jae Hwan ^a   Prymakowska Bosak, Marta ^a   West, Katherine L ^a   Postnikov, Yuri V ^a   Haines, Diana C ^b   Bustin, Michael ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME PROTEIN; HIGH MOBILITY GROUP N1 PROTEIN;

ANIMAL CELL; ARTICLE; CARCINOGENICITY; CELL CYCLE G2 PHASE; CELL GROWTH; CELL PROLIFERATION; CHROMATIN; CONTROLLED STUDY; EMBRYO; FIBROBLAST; IONIZING RADIATION; MITOSIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION;

ANIMALS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FIBROBLASTS; G2 PHASE; HMGN1 PROTEIN; MALE; MICE; MICE, NUDE; NEOPLASMS, RADIATION-INDUCED; RADIATION TOLERANCE;

EID: 23044505690     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0310     Document Type: Article

References (34)

1. Peterson CL, Cote J. Cellular machineries for chromosomal DNA repair. Genes Dev 2004;18:602-6.
2. Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W. Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev 2002;12:162-9.
3. Celeste A, Difilippantonio S, Difilippantonio MJ, et al. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 2003;114:371-83.
4. Bassing CH, Suh H, Ferguson DO, et al. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 2003;114:359-70.
5. Marks PA, Richon VM, Breslow R, Rifkind RA. Histone deacetylase inhibitors as new cancer drugs. Curr Opin Oncol 2001;13:477-83.
6. Espinosa JM, Emerson BM. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol Cell 2001; 8:57-69.
7. Klochendler-Yeivin A, Muchardt C, Yaniv M. SWI/SNF chromatin remodeling and cancer. Curr Opin Genet Dev 2002;12:73-9.
8. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003;421:499-506.
9. Shiloh Y, ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003;3:155-68.
10. Green CM, Almouzni G. When repair meets chromatin: first in series on chromatin dynamics. EMBO Rep 2002;3:28-33.
11. Smerdon MJ, Conconi A. Modulation of DNA damage and DNA repair in chromatin. Prog Nucleic Acid Res Mol Biol 1999;62:227-55.
12. Thoma F. Light and dark in chromatin repair: repair of UV-induced DNA lesions by photolyase and nucleotide excision repair. EMBO J 1999;18:6585-98.
13. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004;432:316-23.
14. Bustin M. Chromatin unfolding and activation by HMG(*) chromosomal proteins. Trends Biochem Sci 2001;26:431-7.
15. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999;19:5237-46.
16. Catez F, Brown DT, Misteli T, Bustin M. Competition between histone H1 and HMGN proteins for chromatin binding sites. EMBO Rep 2002;3:760-6.
17. Phair RD, Misteli T. High mobility of proteins in the mammalian cell nucleus. Nature 2000;404:604-9.
18. Ding HF, Rimsky S, Batson SC, Bustin M, Hansen U. Stimulation of RNA polymerase II elongation by chromosmal protein HMG-14. Science 1994;265: 796-9.
19. Trieschmann L, Alfonso PJ, Crippa MP, Wolffe AP, Bustin M. Incorporation of chromosomal proteins HMG-14/-17 into nascent nucleosomes induces an extended chromatin conformation and enhances the utilization of active transcription complexes. EMBO J 1995;14:1478-89.
20. Paranjape SM, Krumm A, Kadonaga JT, HMG17 is a chromatin-specific transcriptional coactivator that increases the efficiency of transcription initiation. Genes Dev 1995;9:1978-91.
21. Vestner B, Bustin M, Gruss C. Stimulation of replication efficiency of a chromatin template by chromosomal protein HMG-17. J Biol Chem 1998;273:9409-14.
22. Birger Y, West KL, Postnikov YV, et al. Chromosomal protein HMGN1 enhances the rate of DNA repair in chromatin. EMBO J 2003;22:1665-75.
23. Rogakou EP, Boon C, Redon C, Bonner WM. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 1999;146:905-16.
24. Celeste A, Petersen S, Romanienko PJ, et al. Genomic instability in mice lacking histone H2AX. Science 2002; 296:922-7.
25. Prymakowska-Bosak M, Misteli T, Herrera JE, et al. Mitotic phosphorylation prevents the binding of HMGN proteins to chromatin. Mol Cell Biol 200;21:5169-78.
26. Lim JH, Catez F, Birger Y, et al. Chromosomal protein HMGN1 modulates histone H3 phosphorylation. Mol Cell 2004;15:573-84.
27. Celeste A, Fernandez-Capetillo O, Kruhlak MJ, et al. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat Cell Biol 2003;5: 675-9.
28. Fernandez-Capetillo O, Nussenzweig A. Linking histone deacetylation with the repair of DNA breaks. Proc Natl Acad Sci U S A 2004;101:1427-8.
29. Fernandez-Capetillo O, Allis CD, Nussenzweig A. Phosphorylation of histone H2B at DNA double-strand breaks. J Exp Med 2004;199:1671-7.
30. Fernandez-Capetillo O, Chen HT, Celeste A, et al. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol 2002;4:993-7.
31. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000;408:433-9.
32. Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner WM, Barrett JC. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol 2004;6:168-70.
33. Kamijo T, Zindy F, Roussel MF, et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997; 91:649-59.
34. Hollander MC, Fornace AJ Jr. Genomic instability, centrosome amplification, cell cycle checkpoints and Gadd45a. Oncogene 2002;21:6228-33.